pharma · Dermatomyositis · Diffuse Cutaneous Systemic Sclerosis · CRBP
Corbus Pharmaceuticals
Corbus Pharmaceuticals Holdings
Corbus Pharmaceuticals is a pharma organization headquartered in Norwood, USA. It trades on NYSE under ticker CRBP. Primary therapeutic focus areas include Dermatomyositis, Diffuse Cutaneous Systemic Sclerosis, Cystic Fi
500 River Ridge Dr, Norwood, Massachusetts 02062, US HQ
2014 Founded
57 Employees
Public company Type
CRBP · NYSE Ticker
Company details
- Status
- Public
- HQ
- 500 River Ridge Dr, Norwood, Massachusetts 02062, US
- Founded
- 2014
- Employees
- 57
- Programs
- 11
- Drugs
- 3
- Patents
- 6
JBT-101 (lenabasum)
Phase 2 · small molecule · Cystic Fibrosis
JBT-101 (lenabasum) for Cystic Fibrosis is a Phase 2 program (small_molecule) at Corbus Pharmaceuticals Holdings with 1 ClinicalTrials.gov record(s).
Internal code JBT101-CF-001
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Corbus Pharmaceuticals Holdings
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Cystic Fibrosis
- Status
- completed
- Trials
- 1